International Center - China Medical University Hospital

Other Hospital CMUH APP icon

Department Introduction

血液腫瘤科

:::

Department Introduction/

International Center/

Journal Article

Journal Article

Condition：Journal Article -

Time

Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer

Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer

Trastuzumab Deruxtecan or Ramucirumab plus Paclitaxel in Gastric Cancer

Trastuzumab Deruxtecan or Ramucirumab plus Paclitaxel in Gastric Cancer

Lenvatinib Plus Pembrolizumab and Chemotherapy Versus Chemotherapy in Advanced Metastatic Gastroesophageal Adenocarcinoma: The Phase III, Randomized LEAP-015 Study

Lenvatinib Plus Pembrolizumab and Chemotherapy Versus Chemotherapy in Advanced Metastatic Gastroesophageal Adenocarcinoma: The Phase III, Randomized LEAP-015 Study

$INTEGRATE IIa Phase III Study: Regorafenib for Refractory Advanced Gastric Cancer$

INTEGRATE IIa Phase III Study: Regorafenib for Refractory Advanced Gastric Cancer

Intraperitoneal nivolumab for malignant ascites in patients with advanced gastrointestinal or pancreaticobiliary tract cancer

Intraperitoneal nivolumab for malignant ascites in patients with advanced gastrointestinal or pancreaticobiliary tract cancer

Safety, Efficacy, and Pharmacokinetics of SHR-A1811, a Human Epidermal Growth Factor Receptor 2-Directed Antibody-Drug Conjugate, in Human Epidermal Growth Factor Receptor 2-Expressing or Mutated Advanced Solid Tumors: A Global Phase I Trial

Safety, Efficacy, and Pharmacokinetics of SHR-A1811, a Human Epidermal Growth Factor Receptor 2-Directed Antibody-Drug Conjugate, in Human Epidermal Growth Factor Receptor 2-Expressing or Mutated Advanced Solid Tumors: A Global Phase I Trial

Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first-line treatment for advanced or metastatic oesophageal squamous cell carcinoma (RATIONALE-306): a global, randomised, placebo-controlled, phase 3 study

Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first-line treatment for advanced or metastatic oesophageal squamous cell carcinoma (RATIONALE-306): a global, randomised, placebo-controlled, phase 3 study

Silmitasertib Plus Gemcitabine and Cisplatin First-Line Therapy in Locally Advanced/Metastatic Cholangiocarcinoma: a Phase 1b/2 Study

Silmitasertib Plus Gemcitabine and Cisplatin First-Line Therapy in Locally Advanced/Metastatic Cholangiocarcinoma: a Phase 1b/2 Study

Whole-Brain Radiotherapy Alone vs Preceded by Bevacizumab, Etoposide, and Cisplatin for Untreated Brain Metastases From Breast Cancer: A Randomized Clinical Trial

Whole-Brain Radiotherapy Alone vs Preceded by Bevacizumab, Etoposide, and Cisplatin for Untreated Brain Metastases From Breast Cancer: A Randomized Clinical Trial

Ivosidenib and Azacitidine in IDH1-Mutated Acute Myeloid Leukemia

Ivosidenib and Azacitidine in IDH1-Mutated Acute Myeloid Leukemia

s

Stay connected with CMUH

youtube

How to get to CMUH the map of hospital

Download

▲

百度搜狗 360搜索猫和老鼠封总，太太想跟你离婚很久了不速之客爱国者薄冰

<code id='4fdd8'></code><style id='b8280'></style>

<acronym id='8a8e3'></acronym>

<center id='c01a9'><center id='7a861'><tfoot id='8f1a7'></tfoot></center><abbr id='2d379'><dir id='9ee2c'><tfoot id='3e1dc'></tfoot><noframes id='6d57d'>

<optgroup id='984a3'><strike id='cf35d'><sup id='5bd7f'></sup></strike><code id='31c07'></code></optgroup>

<b id='cb99f'><label id='5b28f'><select id='f8c38'><dt id='27c55'><span id='4f0ae'></span></dt></select></label></b><u id='8887c'></u>

~~<i id='7e0d9'><strike id='eb26d'><tt id='4ccb6'><pre id='bed0c'></pre></tt></strike></i>~~